Raleigh Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Buy
1,498
+68
+5% +$14.1K 0.11% 163
2026
Q1
$302K Buy
1,430
+25
+2% +$5.38K 0.1% 173
2025
Q4
$289K Buy
1,405
+175
+14% +$32.9K 0.1% 173
2025
Q3
$193K Buy
1,230
+112
+10% +$17.3K 0.07% 189
2025
Q2
$188K Buy
1,118
+89
+9% +$13.2K 0.08% 205
2025
Q1
$142K Buy
1,029
+565
+122% +$72K 0.06% 216
2024
Q4
$54.9K Buy
464
+106
+30% +$12.4K 0.02% 303
2024
Q3
$39.6K Sell
358
-27
-7% -$2.82K 0.02% 351
2024
Q2
$37.9K Sell
385
-240
-38% -$24.5K 0.02% 335
2024
Q1
$69.9K Buy
625
+351
+128% +$37.9K 0.03% 265
2023
Q4
$27.6K Buy
274
+268
+4,467% +$26.6K 0.01% 380
2023
Q3
$501 Buy
+6
New +$542 ﹤0.01% 880

Other funds holding CAH

Raleigh Capital Management's CAH Position: Q2 2026 in Review

Raleigh Capital Management increased its Cardinal Health (CAH) stake by 4.8% in Q2 2026, buying an estimated $14.1K and bringing the position to 1,498 shares worth $356K. The position accounts for 0.11% of the portfolio, ranked #163.

Raleigh Capital Management first reported a position in CAH in Q3 2023 and has held it in 12 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Raleigh Capital Management held 1,498 shares of Cardinal Health worth $356K as of Q2 2026.
  • Raleigh Capital Management bought 68 Cardinal Health shares in Q2 2026, an estimated $14.1K.
  • Cardinal Health made up 0.11% of Raleigh Capital Management's portfolio in Q2 2026, its #163 holding.
  • Raleigh Capital Management first reported a position in Cardinal Health in Q3 2023 and has held it in 12 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.